Old Web
English
Sign In
Acemap
>
authorDetail
>
J. Patel
J. Patel
GlaxoSmithKline
Medicine
Tolerability
Lupus erythematosus
Immunology
Diabetes mellitus
3
Papers
109
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety, tolerability, efficacy and pharmacodynamics of the selective JAK1 inhibitor GSK2586184 in patients with systemic lupus erythematosus
2016
Lupus
L Kahl
J. Patel
M Layton
M Binks
K.J. Hicks
G. León
Eric Hachulla
D. Machado
D. Staumont-Sallé
M. Dickson
L Condreay
L.A. Schifano
S Zamuner
R. van Vollenhoven
Show All
Source
Cite
Save
Citations (32)
DRESS syndrome and reversible liver function abnormalities in patients with systemic lupus erythematosus treated with the highly selective JAK-1 inhibitor GSK2586184.
2015
Lupus
R. van Vollenhoven
M Layton
L Kahl
L Schifano
Eric Hachulla
D. Machado
D. Staumont-Sallé
J. Patel
Show All
Source
Cite
Save
Citations (20)
Phase II Trial of Topotecan and Cisplatin in Persistent or Recurrent Squamous and Nonsquamous Carcinomas of the Cervix
2002
Gynecologic Oncology
James V. Fiorica
R.W. Holloway
B. Ndubisi
James W. Orr
Edward C. Grendys
R. Boothby
Steven L. DeCesare
J. LaPolla
Mitchel S. Hoffman
J. Patel
Show All
Source
Cite
Save
Citations (57)
1